Fig. 1From: The predictive value of [18F]FDG PET/CT radiomics combined with clinical features for EGFR mutation status in different clinical staging of lung adenocarcinomaFlow chart of patient selection. EGFR epidermal growth factor receptor, NECS neuroendocrine carcinomas, NSCC-NOS non-small cell carcinoma-not otherwise specifiedBack to article page